Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRP | O00591 | 3/20 | 1.00 |
| ▸ | GABRD | O14764 | 3/20 | 1.00 |
| ▸ | GABRA1 | P14867 | 3/20 | 1.00 |
| ▸ | GABRB1 | P18505 | 3/20 | 1.00 |
| ▸ | GABRG2 | P18507 | 3/20 | 1.00 |
| ▸ | GABRB3 | P28472 | 3/20 | 1.00 |
| ▸ | GABRA5 | P31644 | 3/20 | 1.00 |
| ▸ | GABRA3 | P34903 | 3/20 | 1.00 |
| ▸ | GABRA2 | P47869 | 3/20 | 1.00 |
| ▸ | GABRB2 | P47870 | 3/20 | 1.00 |
| ▸ | GABRA4 | P48169 | 3/20 | 1.00 |
| ▸ | GABRE | P78334 | 3/20 | 1.00 |
| ▸ | GABRA6 | Q16445 | 3/20 | 1.00 |
| ▸ | GABRG1 | Q8N1C3 | 3/20 | 1.00 |
| ▸ | GABRG3 | Q99928 | 3/20 | 1.00 |
| ▸ | GABRQ | Q9UN88 | 3/20 | 1.00 |
| ▸ | KDM4C | Q9H3R0 | 7/20 | 0.61 |
| ▸ | KDM5C | P41229 | 6/20 | 0.61 |
| ▸ | KDM2A | Q9Y2K7 | 5/20 | 0.61 |
| ▸ | KDM3A | Q9Y4C1 | 5/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30705741 | 1.00 | GABRP (1.00) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| Hydrochloric Acid SCHEMBL22797869 | 0.98 | GABRP (0.96) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| Nitrous Acid SCHEMBL28394532 | 0.92 | GABRP (0.85) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL446809 | 0.83 | GABRP (0.70) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL31661275 | 0.81 | GABRP (0.68) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL1159738 | 0.81 | GABRP (0.68) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL19586492 | 0.81 | GABRP (0.68) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| Hydrochloric Acid SCHEMBL6227701 | 0.79 | GABRP (0.66) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL1417739 | 0.78 | GABRP (0.63) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL26093618 | 0.78 | GABRP (0.63) | GABRPGABRDGABRA1GABRB1GABRG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 709 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122037226-A | Bimetallic-organic framework material for trapping trifluoromethane, preparation method thereof and adsorbent based on bimetallic-organic framework material | 西安交通大学 | 2026-05-15 | — | — | CN | claimed |
| CN-119753728-A | Preparation method of ordered defective indium cluster frame porous material for electrocatalytic conversion of carbon dioxide to urea | 东北师范大学 | 2025-04-04 | — | — | CN | claimed |
| CN-119659103-A | Non-woven fabric welding coating and preparation method thereof | 华洋(苏州)新材料科技有限公司 | 2025-03-21 | — | — | CN | claimed |
| US-12151046-B2 | Composite antibacterial hydrogel dressing, preparation method and application thereof | GUANGDONG OCEAN UNIVERSITY (CN) | 2024-11-26 | — | — | US | claimed |
| US-20240277894-A1 | COMPOSITE ANTIBACTERIAL HYDROGEL DRESSING, PREPARATION METHOD AND APPLICATION THEREOF | GUANGDONG OCEAN UNIVERSITY (CN) | 2024-08-22 | — | — | US | claimed |
| WO-2024139662-A1 | COMPOSITE ANTIBACTERIAL HYDROGEL DRESSING, PREPARATION METHOD THEREFOR, AND USE THEREOF | 广东海洋大学 | 2024-07-04 | — | — | WO | claimed |
| US-11992563-B2 | Composite material for rapid blood clotting and preparation method thereof | GUANGDONG OCEAN UNIVERSITY (CN) | 2024-05-28 | — | — | US | claimed |
| CN-118005944-A | Antibacterial metal organic framework composite material and preparation method and application thereof | 中国科学院赣江创新研究院 | 2024-05-10 | — | — | CN | claimed |
| CN-117696012-A | Metal organic framework material and preparation method and application thereof | 浙江大学 | 2024-03-15 | — | — | CN | claimed |
| CN-117659427-A | Cd-3-aminopyridine-4-formic acid-MOFs material and preparation method and application thereof | 河南师范大学 | 2024-03-08 | — | — | CN | claimed |
| EP-3317252-A1 | A GENERAL PROCESS FOR THE PREPARATION OF 6-SUBSTITUTED OR 5,6-DISUBSTITUTED DERIVATIVES OF 2-AMINO-ISONICOTINIC ACID | Boehringer Ingelheim International GmbH (DE) | 2018-05-09 | — | — | EP | claimed |
| US-9783905-B2 | Reaction products of amino acids and epoxies | Rohm and Haas Electronic Mateirals LLC (US) | 2017-10-10 | — | — | US | claimed |
| US-20170218533-A1 | REACTION PRODUCTS OF AMINO ACIDS AND EPOXIES | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2017-08-03 | — | — | US | claimed |
| CN-105237472-B | Substituted pyridine complex and preparation method therefor as well as application of substituted pyridine complex as nonlinear optical material, ferroelectric material and fluorescent material | 淮南师范学院 | 2017-02-15 | — | — | CN | claimed |
| WO-2017001670-A1 | A GENERAL PROCESS FOR THE PREPARATION OF 6-SUBSTITUTED OR 5,6-DISUBSTITUTED DERIVATIVES OF 2-AMINO-ISONICOTINIC ACID | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2017-01-05 | — | — | WO | claimed |
| CN-105237472-A | Substituted pyridine complex and preparation method therefor as well as application of substituted pyridine complex as nonlinear optical material, ferroelectric material and fluorescent material | UNIV HUAINAN NORMAL | 2016-01-13 | — | — | CN | claimed |
| CN-104130256-A | Preparation method for pyridine[3, 4-d]pyrimidine-4(3H)-one derivative | BIDE PHARMATECH LTD | 2014-11-05 | — | — | CN | claimed |
| WO-2007117482-A2 | RENIN INHIBITORS | VITAE PHARMACEUTICALS, INC. (US) | 2007-10-18 | — | — | WO | claimed |
| US-20020010344-A1 | Polycyclic aryl and heteroaryl substituted 1,4-quinones useful for selective inhibition of the coagulation cascade | PHARMACIA CORPORATION | 2002-01-24 | — | — | US | claimed |
| EP-0409119-B1 | N,N'-Bis(alkoxy-alkyl)-pyridine-2,4-dicarboxylic acid amides, process for their preparation as well as their use | HOECHST AG (DE) | 1994-04-13 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020010344-A1 | Polycyclic aryl and heteroaryl substituted 1,4-quinones useful for selective inhibition of the coagulation cascade | TFPI, SERPINC1, F2 | GABRP 3231/4885GABRD 2293/4885GABRA1 2858/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.